{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:02:09Z","timestamp":1791385329818,"version":"4.3.3"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine implicated in the pathogenesis of inflammation and cancer. It is produced by various cells and circulating MIF has been identified as a biomarker for a range of diseases. Extracellular MIF mainly binds to the cluster of differentiation 74 (CD74)\/CD44 to activate downstream signaling pathways. These in turn activate immune responses, enhance inflammation and can promote cancer cell proliferation and invasion. Extracellular MIF also binds to the C-X-C chemokine receptors cooperating with or without CD74 to activate chemokine response. Intracellular MIF is involved in Toll-like receptor and inflammasome-mediated inflammatory response. Pharmacological inhibition of MIF has been shown to hold great promise in treating inflammatory diseases and cancer, including small molecule MIF inhibitors targeting the tautomerase active site of MIF and antibodies that neutralize MIF. In the current review, we discuss the role of MIF signaling pathways in inflammation and cancer and summarize the recent advances of the role of MIF in experimental and clinical exocrine pancreatic diseases. We expect to provide insights into clinical translation of MIF antagonism as a strategy for treating acute pancreatitis and pancreatic cancer.<\/jats:p>","DOI":"10.3389\/fphar.2021.638950","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T08:58:37Z","timestamp":1615453117000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer"],"prefix":"10.3389","volume":"12","author":[{"given":"Yongjian","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lohitha","family":"Putha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Windsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D. A.","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1096\/fj.15-273904","article-title":"MIF interacts with CXCR7 to promote receptor internalization, ERK1\/2 and ZAP-70 signaling, and lymphocyte chemotaxis","volume":"29","author":"Alampour-Rajabi","year":"2015","journal-title":"Faseb j"},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00011-007-5184-9","article-title":"Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation","volume":"56","author":"Amano","year":"2007","journal-title":"Inflamm. Res."},{"key":"B3","first-page":"1671","article-title":"Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum","volume":"29","author":"Amoli","year":"2002","journal-title":"J. Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41424-018-0008-5","article-title":"Plasma inflammatory cytokines and survival of pancreatic cancer patients","volume":"9","author":"Babic","year":"2018","journal-title":"Clin. Transl Gastroenterol."},{"key":"B5","first-page":"235","article-title":"Migration inhibitory factor expression in experimentally induced endotoxemia","volume":"150","author":"Bacher","year":"1997","journal-title":"Am. J. Pathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/sj.gene.6363867","article-title":"A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis","volume":"3","author":"Baugh","year":"2002","journal-title":"Genes Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/365756a0","article-title":"MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia","volume":"365","author":"Bernhagen","year":"1993","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"14144","DOI":"10.1021\/bi00251a025","article-title":"Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF)","volume":"33","author":"Bernhagen","year":"1994","journal-title":"Biochemistry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.153.3731.80","article-title":"Mechanism of a reaction in vitro associated with delayed-type hypersensitivity","volume":"153","author":"Bloom","year":"1966","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26502","DOI":"10.1074\/jbc.M116.743328","article-title":"Identification of iguratimod as an inhibitor of macrophage migration inhibitory factor (MIF) with steroid-sparing potential","volume":"291","author":"Bloom","year":"","journal-title":"J. Biol. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1080\/14728222.2016.1251582","article-title":"MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development","volume":"20","author":"Bloom","year":"","journal-title":"Expert Opin. Ther. Targets"},{"key":"B13","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1681\/ASN.V13suppl_1s7","article-title":"Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis","volume":"13","author":"Brown","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"32425","DOI":"10.1074\/jbc.M109.047092","article-title":"Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanates","volume":"284","author":"Brown","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"Calandra","year":"1994","journal-title":"J. Exp. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/72262","article-title":"Protection from septic shock by neutralization of macrophage migration inhibitory factor","volume":"6","author":"Calandra","year":"2000","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/MPA.0b013e3181dac920","article-title":"Pilot study of blood biomarker candidates for detection of pancreatic cancer","volume":"39","author":"Chen","year":"2010","journal-title":"Pancreas"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/carcin\/bgt239","article-title":"Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis","volume":"34","author":"Choudhary","year":"2013","journal-title":"Carcinogenesis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.4049\/jimmunol.181.4.2330","article-title":"Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase","volume":"181","author":"Coleman","year":"2008","journal-title":"J. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat. Cel Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/07357900802672746","article-title":"Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma","volume":"27","author":"Cui","year":"2009","journal-title":"Cancer Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3748\/wjg.v16.i15.1845","article-title":"Different profiles of cytokine expression during mild and severe acute pancreatitis","volume":"16","author":"Dambrauskas","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction","volume":"56","author":"David","year":"1966","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e7312","DOI":"10.1097\/MD.0000000000007312","article-title":"Plasma cytokines can help to identify the development of severe acute pancreatitis on admission","volume":"96","author":"Deng","year":"2017","journal-title":"Medicine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jss.2009.03.048","article-title":"Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells","volume":"160","author":"Denz","year":"2010","journal-title":"J. Surg. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1042\/BJ20140612","article-title":"Potent inhibition of macrophage migration inhibitory factor (MIF) by myeloperoxidase-dependent oxidation of epicatechins","volume":"462","author":"Dickerhof","year":"2014","journal-title":"Biochem. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#","article-title":"A novel 5\u2019-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis","volume":"44","author":"Donn","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s003359900858","article-title":"Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF","volume":"9","author":"Esumi","year":"1998","journal-title":"Mamm. Genome"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3389\/fimmu.2020.01273","article-title":"Role of MIF cytokine\/CD74 receptor pathway in protecting against injury and promoting repair","volume":"11","author":"Farr","year":"2020","journal-title":"Front. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1373\/clinchem.2007.093195","article-title":"Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer","volume":"54","author":"Fredriksson","year":"2008","journal-title":"Clin. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/ijc.27736","article-title":"Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma","volume":"132","author":"Funamizu","year":"2013","journal-title":"Int. J. Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1189\/jlb.3MA0915-418R","article-title":"Macrophage migration inhibitory factor drives neutrophil accumulation by facilitating IL-1\u03b2 production in a murine model of acute gout","volume":"99","author":"Galv\u00e3o","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13058-019-1243-8","article-title":"A window-of-opportunity trial of the CXCR1\/2 inhibitor reparixin in operable HER-2-negative breast cancer","volume":"22","author":"Goldstein","year":"2020","journal-title":"Breast Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1074\/jbc.M703265200","article-title":"Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex","volume":"283","author":"Gore","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1517\/14728220903551304","article-title":"Autoimmune diseases: MIF as a therapeutic target","volume":"14","author":"Greven","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1053\/j.gastro.2017.08.071","article-title":"Autophagy, inflammation, and immune dysfunction in the pathogenesis of pancreatitis","volume":"153","author":"Gukovskaya","year":"2017","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1002\/ijc.30278","article-title":"D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth","volume":"139","author":"Guo","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/jog.13538","article-title":"Fetal liver injury ameliorated by migration inhibitory factor inhibition in a rat model of acute pancreatitis in pregnancy","volume":"44","author":"Guo","year":"2018","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1053\/j.gastro.2018.11.082","article-title":"Acute pancreatitis: a multifaceted set of organelle and cellular interactions","volume":"156","author":"Habtezion","year":"2019","journal-title":"Gastroenterology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1096\/fj.09-152223","article-title":"Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction","volume":"24","author":"Harper","year":"2010","journal-title":"FASEB J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.it.2019.03.002","article-title":"Rediscovering MIF: new tricks for an old cytokine","volume":"40","author":"Harris","year":"2019","journal-title":"Trends Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2119\/molmed.2008.00107","article-title":"Macrophage migration inhibitory factor promotes colorectal cancer","volume":"15","author":"He","year":"2009","journal-title":"Mol. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2174\/0929867324666170714114200","article-title":"Macrophage migration inhibitory factor\u2014a favorable marker in inflammatory diseases?","volume":"25","author":"Hertelendy","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.190.10.1375","article-title":"A proinflammatory cytokine inhibits p53 tumor suppressor activity","volume":"190","author":"Hudson","year":"1999","journal-title":"J. Exp. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1158\/1535-7163.MCT-12-0988","article-title":"Human anti-macrophage migration inhibitory factor antibodies inhibit growth of human prostate cancer cells in vitro and in vivo","volume":"12","author":"Hussain","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"155121","DOI":"10.1016\/j.cyto.2020.155121","article-title":"Immune modulation by the macrophage migration inhibitory factor (MIF) family: D-dopachrome tautomerase (DDT) is not (always) a backup system","volume":"133","author":"Illescas","year":"2020","journal-title":"Cytokine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3892\/ijo.2014.2551","article-title":"ISO-66, a novel inhibitor of macrophage migration inhibitory factor, shows efficacy in melanoma and colon cancer models","volume":"45","author":"Ioanou","year":"2014","journal-title":"Int. J. Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","article-title":"Evolving complexity of MIF signaling","volume":"57","author":"Jankauskas","year":"2019","journal-title":"Cell Signal."},{"key":"B51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/bjh.12565","article-title":"Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma","volume":"163","author":"Kaufman","year":"2013","journal-title":"Br. J. Haematol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1038\/emm.2015.26","article-title":"The macrophage migration inhibitory factor protein superfamily in obesity and wound repair","volume":"47","author":"Kim","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00432-013-1375-7","article-title":"Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies","volume":"139","author":"Kindt","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/35041591","article-title":"Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1","volume":"408","author":"Kleemann","year":"2000","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.drudis.2018.06.017","article-title":"Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders","volume":"23","author":"Kok","year":"2018","journal-title":"Drug Discov. Today"},{"key":"B57","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/bjc.2013.348","article-title":"Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma","volume":"109","author":"Kondo","year":"2013","journal-title":"Br. J. Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1038\/s41467-018-04581-2","article-title":"Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation","volume":"9","author":"Lang","year":"2018","journal-title":"Nat. Commun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00134-009-1640-z","article-title":"Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor","volume":"36","author":"Leaver","year":"2010","journal-title":"Intensive Care Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/15548627.2016.1164358","article-title":"Loss of autophagy enhances MIF\/macrophage migration inhibitory factor release by macrophages","volume":"12","author":"Lee","year":"2016","journal-title":"Autophagy"},{"key":"B61","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41575-019-0158-2","article-title":"New insights into acute pancreatitis","volume":"16","author":"Lee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74","volume":"197","author":"Leng","year":"2003","journal-title":"J. Exp. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.intimp.2018.12.068","article-title":"Inhibition of macrophage migration inhibitory factor attenuates inflammation and fetal kidney injury in a rat model of acute pancreatitis in pregnancy","volume":"68","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nri3743","article-title":"Regulated cell death and inflammation: an auto-amplification loop causes organ failure","volume":"14","author":"Linkermann","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine patterns in patients with cancer: a systematic review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00432-012-1330-z","article-title":"Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential","volume":"139","author":"Liu","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1038\/sj.onc.1210318","article-title":"Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5\/JAB1 in the control of autocrine MIF activity","volume":"26","author":"Lue","year":"2007","journal-title":"Oncogene"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ajpath.2017.08.017","article-title":"Human pancreatic acinar cells: proteomic characterization, physiologic responses, and organellar disorders in ex Vivo pancreatitis","volume":"187","author":"Lugea","year":"2017","journal-title":"Am. J. Pathol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/bcp.14289","article-title":"Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours","volume":"86","author":"Mahalingam","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B70","first-page":"289","article-title":"Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis","volume":"8","author":"Makhija","year":"2007","journal-title":"Jop"},{"key":"B71","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1165\/rcmb.2005-0272OC","article-title":"Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia","volume":"35","author":"Matsuda","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2119\/molmed.2014.00136","article-title":"Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer","volume":"20","author":"Mawhinney","year":"2015","journal-title":"Mol. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"E577","DOI":"10.1073\/pnas.1102941108","article-title":"The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)","volume":"108","author":"Merk","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/cncr.10354","article-title":"Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma","volume":"94","author":"Meyer-Siegler","year":"2002","journal-title":"Cancer"},{"key":"B75","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.4049\/jimmunol.158.11.5514","article-title":"Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice","volume":"158","author":"Mikulowska","year":"1997","journal-title":"J. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"18100","DOI":"10.1074\/jbc.274.25.18100","article-title":"Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action","volume":"274","author":"Mitchell","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1073\/pnas.012511599","article-title":"Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response","volume":"99","author":"Mitchell","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B78","doi-asserted-by":"publisher","first-page":"CD011384","DOI":"10.1002\/14651858.CD011384.pub2","article-title":"Pharmacological interventions for acute pancreatitis","volume":"4","author":"Moggia","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B79","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fimmu.2015.00308","article-title":"Role of macrophage migration inhibitory factor in obesity, insulin resistance, type 2 diabetes, and associated hepatic Co-morbidities: a comprehensive review of human and rodent studies","volume":"6","author":"Morrison","year":"2015","journal-title":"Front. Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1046\/j.1365-2990.2002.00416.x","article-title":"Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression","volume":"28","author":"Munaut","year":"2002","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0304-3940(96)12864-0","article-title":"Presence of macrophage migration inhibitory factor (MIF) in ependyma, astrocytes and neurons in the bovine brain","volume":"213","author":"Nishibori","year":"1996","journal-title":"Neurosci. Lett."},{"key":"B82","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1006\/bbrc.1998.8123","article-title":"Molecular cloning of human D-dopachrome tautomerase cDNA: N-terminal proline is essential for enzyme activation","volume":"243","author":"Nishihira","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B83","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/med.21385","article-title":"Targeting MIF in cancer: therapeutic strategies, current developments, and future opportunities","volume":"36","author":"O\u2019reilly","year":"2016","journal-title":"Med. Res. Rev."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e2215","DOI":"10.1371\/journal.pone.0002215","article-title":"Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner","volume":"3","author":"Oda","year":"2008","journal-title":"PLoS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/gast.2002.34236","article-title":"Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice","volume":"123","author":"Ohkawara","year":"2002","journal-title":"Gastroenterology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.lfs.2017.09.015","article-title":"Protective effect of chlorogenic acid on the inflammatory damage of pancreas and lung in mice with l-arginine-induced pancreatitis","volume":"190","author":"Ohkawara","year":"2017","journal-title":"Life Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/1471-2407-14-630","article-title":"Macrophage migration inhibitory factor engages PI3K\/Akt signalling and is a prognostic factor in metastatic melanoma","volume":"14","author":"Oliveira","year":"2014","journal-title":"BMC Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/MPA.0b013e31815bd26a","article-title":"Effects of glucocorticoid agonist and antagonist on the pathogenesis of L-arginine-induced acute pancreatitis in rat","volume":"36","author":"Paszt","year":"2008","journal-title":"Pancreas"},{"key":"B89","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018","volume":"156","author":"Peery","year":"2019","journal-title":"Gastroenterology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41575-018-0087-5","article-title":"Global epidemiology and holistic prevention of pancreatitis","volume":"16","author":"Petrov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.0818-9641.2002.01148.x","article-title":"Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator","volume":"81","author":"Petrovsky","year":"2003","journal-title":"Immunol. Cel Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/01.sla.0000245471.33987.4b","article-title":"Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis","volume":"245","author":"Rahman","year":"2007","journal-title":"Ann. Surg."},{"key":"B93","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/414920a","article-title":"MIF regulates innate immune responses through modulation of Toll-like receptor 4","volume":"414","author":"Roger","year":"2001","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF03402210","article-title":"The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction","volume":"2","author":"Rosengren","year":"1996","journal-title":"Mol. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0014-5793(97)01261-1","article-title":"The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase","volume":"417","author":"Rosengren","year":"1997","journal-title":"FEBS Lett."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e0146102","DOI":"10.1371\/journal.pone.0146102","article-title":"The MIF antagonist ISO-1 attenuates corticosteroid-insensitive inflammation and airways hyperresponsiveness in an ozone-induced model of COPD","volume":"11","author":"Russell","year":"2016","journal-title":"PLoS One"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1053\/gast.2003.50099","article-title":"Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis","volume":"124","author":"Sakai","year":"2003","journal-title":"Gastroenterology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1053\/j.gastro.2019.01.268","article-title":"Early intra-acinar events in pathogenesis of pancreatitis","volume":"156","author":"Saluja","year":"2019","journal-title":"Gastroenterology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1053\/j.gastro.2015.07.066","article-title":"Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis","volume":"149","author":"Sankaran","year":"2015","journal-title":"Gastroenterology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"73486","DOI":"10.18632\/oncotarget.11970","article-title":"Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer","volume":"7","author":"Schinagl","year":"2016","journal-title":"Oncotarget"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.febslet.2009.07.058","article-title":"A functional heteromeric MIF receptor formed by CD74 and CXCR4","volume":"583","author":"Schwartz","year":"2009","journal-title":"FEBS Lett."},{"key":"B103","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.gastro.2019.09.040","article-title":"NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis","volume":"158","author":"Sendler","year":"2020","journal-title":"Gastroenterology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gut.2008.170423","article-title":"Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice","volume":"58","author":"Sharif","year":"2009","journal-title":"Gut"},{"key":"B105","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12876-020-01598-0","article-title":"Macrophage migration inhibitory factor is an early marker of severe acute pancreatitis based on the revised Atlanta classification","volume":"21","author":"Shen","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.4049\/jimmunol.1103355","article-title":"U1-Small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes","volume":"188","author":"Shin","year":"2012","journal-title":"J. Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.40672","article-title":"Macrophage migration inhibitory factor regulates U1 small nuclear RNP immune complex-mediated activation of the NLRP3 inflammasome","volume":"71","author":"Shin","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1096\/fj.201701189R","article-title":"Novel half-life extended anti-MIF nanobodies protect against endotoxic shock","volume":"32","author":"Sparkes","year":"2018","journal-title":"FASEB J."},{"key":"B111","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.imbio.2017.05.004","article-title":"Reprint of: the non-mammalian MIF superfamily","volume":"222","author":"Sparkes","year":"2017","journal-title":"Immunobiology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejmech.2015.02.012","article-title":"Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor","volume":"93","author":"Spencer","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1182\/blood-2004-03-0890","article-title":"Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies","volume":"104","author":"Stein","year":"2004","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1158\/1078-0432.CCR-08-1953","article-title":"Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell lines","volume":"15","author":"Stein","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.clinthera.2010.05.007","article-title":"Plerixafor: a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin\u2019s lymphoma or multiple myeloma","volume":"32","author":"Steinberg","year":"2010","journal-title":"Clin. Ther."},{"key":"B116","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1021\/bi982184o","article-title":"Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution","volume":"38","author":"Sugimoto","year":"1999","journal-title":"Biochemistry"},{"key":"B117","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1073\/pnas.93.11.5191","article-title":"Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor","volume":"93","author":"Sun","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B118","doi-asserted-by":"publisher","first-page":"15507","DOI":"10.1038\/s41598-019-51947-7","article-title":"Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human counterpart and promotes pancreatic cancer","volume":"9","author":"Suresh","year":"2019","journal-title":"Sci. Rep."},{"key":"B119","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nsb0396-259","article-title":"Crystal structure of the macrophage migration inhibitory factor from rat liver","volume":"3","author":"Suzuki","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1479-5876-12-92","article-title":"Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of \u03b2-cell","volume":"12","author":"Tan","year":"2014","journal-title":"J. Transl Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin. Immunol."},{"key":"B122","first-page":"3755","article-title":"Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance","volume":"8","author":"Tomiyasu","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1021\/acs.jmedchem.8b00589","article-title":"Advances and insights for small molecule inhibition of macrophage migration inhibitory factor","volume":"61","author":"Trivedi-Parmar","year":"2018","journal-title":"J. Med. Chem."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1053\/j.gastro.2018.01.031","article-title":"Initial medical treatment of acute pancreatitis: American gastroenterological association institute technical review","volume":"154","author":"Vege","year":"2018","journal-title":"Gastroenterology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1073\/pnas.94.9.4782","article-title":"Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor","volume":"94","author":"Waeber","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B126","doi-asserted-by":"publisher","first-page":"A37","DOI":"10.1136\/lupus-2016-000179.73","article-title":"CT-01\u2005Phase IB study of IMMU-115 (humanised ANTI-CD74 antibody) targeting antigen presenting cells in patients with systemic lupus erythematosus (SLE)","volume":"3","author":"Wallace","year":"2016","journal-title":"Lupus Sci. Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10620-018-5379-7","article-title":"Macrophage migration inhibitor promoted the intrahepatic bile duct injury in rats with severe acute pancreatitis","volume":"64","author":"Wang","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.3892\/or.2018.6703","article-title":"Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"key":"B129","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1158\/0008-5472.CAN-06-3292","article-title":"Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization","volume":"67","author":"Winner","year":"2007","journal-title":"Cancer Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S2468-1253(16)30004-8","article-title":"Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies","volume":"1","author":"Xiao","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2007.11.028","article-title":"Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer","volume":"261","author":"Xu","year":"2008","journal-title":"Cancer Lett."},{"key":"B132","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.drudis.2012.12.013","article-title":"Current developments of macrophage migration inhibitory factor (MIF) inhibitors","volume":"18","author":"Xu","year":"2013","journal-title":"Drug Discov. Today"},{"key":"B133","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5114\/pg.2014.40850","article-title":"Treatment with ginkgo biloba extract protects rats against acute pancreatitis-associated lung injury by modulating alveolar macrophage","volume":"9","author":"Xu","year":"2014","journal-title":"Prz Gastroenterol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1158\/0008-5472.CAN-15-2841","article-title":"A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0014-5793(95)01041-c","article-title":"Cloning and sequencing of a cDNA encoding rat D-dopachrome tautomerase","volume":"373","author":"Zhang","year":"1995","journal-title":"FEBS Lett."},{"key":"B136","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.3892\/mmr.2018.8672","article-title":"Macrophage migration inhibitory factor antagonist (S,R)3(4hydroxyphenyl)4,5dihydro5isoxazole acetic acid methyl ester attenuates inflammation and lung injury in rats with acute pancreatitis in pregnancy","volume":"17","author":"Zhou","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B137","doi-asserted-by":"publisher","first-page":"109919","DOI":"10.1016\/j.biopha.2020.109919","article-title":"Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis","volume":"125","author":"Zhu","year":"2020","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.638950\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T23:03:46Z","timestamp":1698015826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.638950\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":137,"alternative-id":["10.3389\/fphar.2021.638950"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.638950","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"article-number":"638950"}}